Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

RedHill Biopharma (RDHL) Shares Outstanding (Weighted Average): 2011-2025

Historic Shares Outstanding (Weighted Average) for RedHill Biopharma (RDHL) over the last 12 years, with Jun 2025 value amounting to $12.9 billion.

  • RedHill Biopharma's Shares Outstanding (Weighted Average) rose 1.20% to $12.9 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $12.9 billion, marking a year-over-year increase of 1.20%. This contributed to the annual value of $12.7 billion for FY2024, which is 897.46% up from last year.
  • Latest data reveals that RedHill Biopharma reported Shares Outstanding (Weighted Average) of $12.9 billion as of Q2 2025, which was up 1.20% from $12.7 billion recorded in Q4 2024.
  • In the past 5 years, RedHill Biopharma's Shares Outstanding (Weighted Average) ranged from a high of $12.9 billion in Q2 2025 and a low of $384.0 million during Q1 2021.
  • For the 3-year period, RedHill Biopharma's Shares Outstanding (Weighted Average) averaged around $6.9 billion, with its median value being $7.0 billion (2023).
  • Data for RedHill Biopharma's Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 980.50% (in 2024) over the last 5 years.
  • Over the past 5 years, RedHill Biopharma's Shares Outstanding (Weighted Average) (Quarterly) stood at $467.9 million in 2021, then skyrocketed by 36.43% to $638.4 million in 2022, then surged by 100.19% to $1.3 billion in 2023, then surged by 897.46% to $12.7 billion in 2024, then increased by 1.20% to $12.9 billion in 2025.
  • Its last three reported values are $12.9 billion in Q2 2025, $12.7 billion for Q4 2024, and $12.7 billion during Q2 2024.